{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:39Z","timestamp":1786985019580,"version":"build-2736575974"},"reference-count":126,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbmt.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T21:02:13Z","timestamp":1488834133000},"page":"882-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies"],"prefix":"10.1016","volume":"23","author":[{"given":"Juliet N.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ballen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Brunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.03.006_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the US registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00277-011-1392-z","article-title":"Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia","volume":"91","author":"Iori","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0025","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematological malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0030","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2011-12-400630","article-title":"Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes","volume":"119","author":"Brunstein","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bbmt.2015.07.029","article-title":"High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia","volume":"21","author":"Ponce","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbmt.2014.10.030","article-title":"Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type","volume":"21","author":"Warlick","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0045","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0050","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2015-06-654780","article-title":"Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells","volume":"126","author":"Hiwarkar","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0055","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2016-06-718619","article-title":"CD4+ T-cell alloreactivity toward mismatched HLA-class II alleles early after double umbilical cord blood transplantation","volume":"128","author":"Lamers","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0060","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbmt.2013.06.006","article-title":"Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia","volume":"19","author":"Peffault de Latour","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbmt.2014.02.020","article-title":"Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a CIBMTR-Eurocord analysis","volume":"20","author":"Weisdorf","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3324\/haematol.2013.094193","article-title":"Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors","volume":"99","author":"Marks","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0075","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/bmt.2014.72","article-title":"Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation","volume":"49","author":"Tucunduva","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/leu.2010.219","article-title":"Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT","volume":"25","author":"Robin","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0085","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbmt.2014.06.011","article-title":"Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis","volume":"20","author":"Robin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2009-11-252601","article-title":"Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis","volume":"116","author":"Takagi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/bmt.2014.259","article-title":"Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor","volume":"50","author":"Bachanova","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0105","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3109\/10428194.2015.1105370","article-title":"Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma","volume":"57","author":"Thompson","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0110","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2015.138917","volume":"101","author":"Paviglianiti","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbmt.2015.02.015","article-title":"Cord blood transplantation for multiple myeloma: a study from the multiple myeloma working group of the Japan Society for Hematopoietic Cell Transplantation","volume":"21","author":"Kawamura","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0120","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.13136","article-title":"Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia","volume":"168","author":"Barker","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0135","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.bbmt.2016.12.282","article-title":"Excellent outcomes in 1589 patients receiving umbilical cord blood transplantation using unlicensed units from a centralized cord blood registry","volume":"23","author":"Ballen","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbmt.2013.02.007","article-title":"A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation","volume":"19","author":"Ponce","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0150","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood.V124.21.1205.1205","article-title":"Comorbidity index in the context of cord blood transplantation: an accurate predictor of treatment related mortality?","volume":"124","author":"Oliver","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0155","doi-asserted-by":"crossref","first-page":"s76","DOI":"10.1016\/j.bbmt.2015.11.370","article-title":"High progression-free survival (PFS) in adult double unit cord blood (dCB) transplant recipients with high-risk disease after a novel intermediate intensity conditioning regimen","volume":"2","author":"Kosuri","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0160","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bbmt.2016.07.022","article-title":"HapLogic: a predictive human leukocyte antigen-matching algorithm to enhance rapid identification of the optimal unrelated hematopoietic stem cell sources for transplantation","volume":"22","author":"Dehn","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0165","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/bmt.2016.162","article-title":"Unrelated donor search prognostic score to support early HLA consultation and clinical decisions","volume":"51","author":"Wadsworth","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2013-05-506253","article-title":"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy","volume":"123","author":"Eapen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0175","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","article-title":"Combined effect of total nucleated cell dose and HLA-match on transplant outcome in 1061 cord bloodrecipients with hematological malignancies","volume":"115","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0180","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0185","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1182\/blood-2014-03-566216","article-title":"Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice","volume":"124","author":"Purtill","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0190","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/bmt.2014.135","article-title":"Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection","volume":"49","author":"Dahi","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0195","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3324\/haematol.2015.127787","article-title":"Better allele-level matching improves transplant-related mortality after double cord blood transplantation","volume":"100","author":"Oran","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbmt.2015.09.025","article-title":"Impact of allele-level HLA mismatch on outcomes in recipients of double umbilical cord blood transplantation","volume":"22","author":"Brunstein","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbmt.2013.10.016","article-title":"Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation","volume":"20","author":"Sanz","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0210","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood.V96.8.2717","article-title":"Cell dose and speed of engraftment in placental\/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity","volume":"96","author":"Migliaccio","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0215","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbmt.2011.01.011","article-title":"Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants","volume":"17","author":"Page","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2009.11.013","article-title":"Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation","volume":"16","author":"Scaradavou","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0225","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2015-08-666990","article-title":"Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay","volume":"127","author":"Shoulars","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbmt.2011.12.588","article-title":"The use of back-up units to enhance the safety of unrelated donor cord blood transplantation","volume":"18","author":"Ponce","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0235","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0240","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2013.259","article-title":"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT","volume":"28","author":"Ruggeri","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0245","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbmt.2015.07.015","article-title":"Association between nondominant unit total nucleated cell dose and engraftment in myeloablative double-unit cord blood transplantation","volume":"21","author":"Purtill","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0250","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0255","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2011.195","article-title":"Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies","volume":"47","author":"Kindwall-Keller","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0260","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3324\/haematol.2013.092254","article-title":"Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France","volume":"99","author":"Labopin","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0265","doi-asserted-by":"crossref","unstructured":"Brunstein C., Zhang M.J., Barker J., et\u00a0al. The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. Haematologica. [Epub ahead of print] doi:10.3324\/haematol.2016.158584.","DOI":"10.3324\/haematol.2016.158584"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0270","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1182\/blood-2011-05-355263","article-title":"Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation","volume":"118","author":"Cutler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0275","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0280","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.bbmt.2011.04.013","article-title":"Anti-HLA antibodies in double umbilical cord blood transplantation","volume":"17","author":"Brunstein","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0285","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbmt.2014.01.017","article-title":"Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies","volume":"20","author":"Dahi","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0290","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2010-04-280966","article-title":"How I treat: the selection and acquisition of unrelated cord blood grafts","volume":"117","author":"Barker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0295","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1182\/blood-2008-12-197467","article-title":"Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity","volume":"113","author":"Brunstein","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0300","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2008.365","article-title":"KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia","volume":"23","author":"Willemze","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0305","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1038\/bcj.2013.62","article-title":"Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission","volume":"3","author":"Tanaka","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0310","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbmt.2016.04.007","article-title":"Killer cell immunoglobulin-like receptor-ligand matching and outcomes after unrelated cord blood transplantation in acute myeloid leukemia","volume":"22","author":"Rocha","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0315","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/bmt.2012.272","article-title":"KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation","volume":"48","author":"Garfall","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2016-03-706317","article-title":"Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation","volume":"128","author":"Sekine","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0325","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bmt.2016.151","volume":"51","author":"Rettman","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0330","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood-2016-06-722249","article-title":"Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation","volume":"129","author":"Cunha","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0335","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1073\/pnas.0910310106","article-title":"Reexposure of cord blood to non-inherited maternal HLA antigens improves transplant outcome in hematological malignancies","volume":"106","author":"van Rood","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0340","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.bbmt.2014.07.011","article-title":"Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks","volume":"20","author":"Van der Zanden","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0345","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.bbmt.2012.07.010","article-title":"Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy","volume":"18","author":"Rocha","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0350","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0355","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2012.13","article-title":"Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen","volume":"47","author":"Sanz","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0360","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2002-11-3337","article-title":"Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning","volume":"102","author":"Barker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0365","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after non-myeloablative conditioning: impact on transplantion outcomes in 110 adults with hematological disease","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0370","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbmt.2013.02.008","article-title":"Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match","volume":"19","author":"Ponce","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0375","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/bmt.2016.186","article-title":"Chronic graft-versus-host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation","volume":"51","author":"Gutman","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0380","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbmt.2015.09.008","article-title":"Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors","volume":"22","author":"Lazaryan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0385","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/bmt.2013.139","article-title":"Higher therapeutic CsA levels early post-transplantation reduce risk of acute GVHD and improves survival","volume":"49","author":"Rogosheske","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0390","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbmt.2016.06.001","article-title":"Analysis of cyclosporine A levels supports new dosing guidelines in adult double-unit cord blood transplant recipients to optimize immunosuppression early post-transplant","volume":"22","author":"Bhatt","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0395","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbmt.2015.01.023","article-title":"Higher dose of mycophenolate mofetil reduces acute graft-versus-host disease in reduced-intensity conditioning double umbilical cord blood transplantation","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0400","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbmt.2015.01.024","article-title":"Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation","volume":"21","author":"Harnicar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0405","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood-2014-06-584789","article-title":"High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation","volume":"125","author":"Ponce","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0410","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bmt.2010.192","article-title":"Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis","volume":"46","author":"Cutler","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0415","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.bbmt.2015.08.022","article-title":"In vivo T cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children","volume":"21","author":"Ponce","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0420","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1182\/blood-2006-03-011791","article-title":"Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation","volume":"108","author":"Brunstein","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0425","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0430","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/bmt.2014.216","article-title":"Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies","volume":"50","author":"Pascal","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0435","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2014-09-599241","article-title":"Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation","volume":"126","author":"Pascal","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0440","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2014.12.023","article-title":"Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies","volume":"21","author":"Zheng","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0445","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0450","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40262-014-0214-6","article-title":"Population pharmacokinetic modeling of Thymoglobulin(\u00ae) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing","volume":"54","author":"Admiraal","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0455","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1073\/pnas.92.22.10119","article-title":"Processing and cryopreservation of placental\/umbilical cord blood for unrelated bone marrow reconstitution","volume":"92","author":"Rubinstein","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0460","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbmt.2013.12.561","article-title":"\u201cNo wash\u201d albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment","volume":"20","author":"Dahi","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0465","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2011-03-341438","article-title":"Response: the controversy of red cell-replete cord blood units","volume":"118","author":"Barker","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0470","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.bbmt.2009.08.009","article-title":"A \u201cno-wash\u201d albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions","volume":"15","author":"Barker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0475","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0480","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3109\/10428194.2014.963079","article-title":"Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant","volume":"56","author":"Dahi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0485","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbmt.2009.09.019","article-title":"Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation","volume":"16","author":"Beck","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0490","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","article-title":"Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients","volume":"118","author":"Milano","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0495","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","article-title":"Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis","volume":"18","author":"Hill","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0500","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbmt.2014.02.010","article-title":"Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin","volume":"20","author":"Olson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0505","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.bbmt.2015.08.010","article-title":"Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies","volume":"21","author":"Shah","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0510","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/bmt.2011.236","article-title":"Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation","volume":"47","author":"Avery","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0515","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0520","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bmt.2010.174","article-title":"GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome","volume":"46","author":"Alsultan","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0525","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2016.288","article-title":"Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation","volume":"31","author":"Kanda","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0530","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.bbmt.2007.06.004","article-title":"Chronic graft versus host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB)","volume":"13","author":"Arora","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0535","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbmt.2009.10.022","article-title":"Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease","volume":"16","author":"Patel","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0540","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/bmt.2012.279","article-title":"Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0545","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood-2012-07-445965","article-title":"New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation","volume":"121","author":"Daikeler","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0550","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/bmt.2014.107","article-title":"Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience","volume":"49","author":"Sanz","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0555","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bmt.2016.228","article-title":"Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab","volume":"51","author":"Bhatt","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0560","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0565","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcyt.2015.02.004","article-title":"Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation","volume":"17","author":"Horwitz","year":"2015","journal-title":"Cytotherapy"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2017.03.006_bib0570","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/bmt.2015.97","article-title":"Umbilical cord blood graft engineering: challenges and opportunities","volume":"50","author":"Thompson","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0575","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm.2080","article-title":"Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution","volume":"16","author":"Delaney","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0580","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1207285","article-title":"Cord-blood engraftment with ex vivo mesenchymal-cell coculture","volume":"367","author":"de Lima","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0585","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1172\/JCI74556","article-title":"Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment","volume":"124","author":"Horwitz","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0590","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","article-title":"Phase I\/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft","volume":"18","author":"Wagner","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0595","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1256337","article-title":"Cord blood expansion: pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal","volume":"345","author":"Fares","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0600","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2011-12-398115","article-title":"Development of a vascular niche platform for expansion of repopulating human cord blood stem and progenitor cells","volume":"120","author":"Butler","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0605","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bmt.2008.329","article-title":"Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor","volume":"43","author":"Bautista","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0610","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0615","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.bbmt.2015.06.001","article-title":"Sufficient immunosuppression with thymoglobulin is essential for a successful haplo-myeloid bridge in haploidentical-cord blood transplantation","volume":"21","author":"Lindemans","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0620","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood-2015-01-607366","article-title":"Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation","volume":"125","author":"Popat","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0625","doi-asserted-by":"crossref","first-page":"285ra63","DOI":"10.1126\/scitranslmed.aaa2546","article-title":"CMV-specific T cells generated from na\u00efve T cells recognize atypical epitopes and may be protective in vivo","volume":"7","author":"Hanley","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0630","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.03.006_bib0635","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated post-transplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T-lymphocytes","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117303245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:58:53Z","timestamp":1761058733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117303245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":126,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1083879117303245"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}